In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC Drug Master File in Korea (NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC. The MFDS reviews the NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC KDMF as part of the drug registration process and uses the information provided in the NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC KDMF to evaluate the safety and efficacy of the drug.
After submitting a NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC suppliers with KDMF on PharmaCompass.